General Information of the Compound
| Compound ID |
CP0439295
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(1-((1R,4R)-2,2-dimethyl-4-((S)-2,2,2-trifluoro-1-(4-methoxyphenyl)ethylamino)cyclohexanecarbonyl)-4-phenylpiperidin-4-yl)(pyrrolidin-1-yl)methanone
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C34H44F3N3O3
|
||||||||||||||||||
| Molecular Weight |
599.738
|
||||||||||||||||||
| Canonical SMILES |
COc1ccc(cc1)[C@H](N[C@@H]1CC[C@@H](C(=O)N2CCC(CC2)(C(=O)N2CCCC2)c2ccccc2)C(C)(C)C1)C(F)(F)F
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C34H44F3N3O3/c1-32(2)23-26(38-29(34(35,36)37)24-11-14-27(43-3)15-12-24)13-16-28(32)30(41)39-21-17-33(18-22-39,25-9-5-4-6-10-25)31(42)40-19-7-8-20-40/h4-6,9-12,14-15,26,28-29,38H,7-8,13,16-23H2,1-3H3/t26-,28+,29+/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
DHGONFXRNQVIET-FGUUHEIUSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02259, Neuropeptide Y receptor type 1
Protein ID: PT00897, Potassium voltage-gated channel subfamily H member 2
Protein ID: PT00871, Sodium-dependent serotonin transporter